Ashley Kaplowitz | executive |
Barry Greene | executive |
Chris Benecchi | executive |
Laura Gault | executive |
Kimi Iguchi | executive |
Anupam Rama | analyst |
Ritu Baral | analyst |
James Condulis | analyst |
Tazeen Ahmad | analyst |
Brian Abrahams | analyst |
Laura Chico | analyst |
Neena Bitritto-Garg | analyst |
George Farmer | analyst |
Sumant Kulkarni | analyst |
Yatin Suneja | analyst |
Michael Quirk | executive |
Vikram Purohit | analyst |
Marc Goodman | analyst |
Good morning. Welcome to Sage Therapeutics' Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors and Media section of Sages' website at sagerx.com. This call is the property of Sage Therapeutics, and recording, reproduction or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited. Please note that this call is being recorded.I would now like to introduce Ashley Kaplowitz, Executive Director of Investor Relations and Capital Markets at Sage.